Mikafungin
Изглед
| Klinički podaci | |
|---|---|
| Drugs.com | Monografija |
| Način primene | Intravenozno |
| Farmakokinetički podaci | |
| Poluvreme eliminacije | 14-17 sati |
| Izlučivanje | Fekalno |
| Identifikatori | |
| CAS broj | 235114-32-6 |
| ATC kod | J02AX05 (WHO) |
| PubChem | CID 477468 |
| DrugBank | DB01141 |
| ChemSpider | 2339421 |
| KEGG | C15819 |
| ChEBI | CHEBI:600520 |
| ChEMBL | CHEMBL1201351 |
| Hemijski podaci | |
| Formula | C56H71N9O23S |
| Molarna masa | 1270,274 |
| |
| |
Mikafungin je organsko jedinjenje, koje sadrži 56 atoma ugljenika i ima molekulsku masu od 1270,274 Da.[1][2][3][4][5][6][7][8][9][10][11][12]
Osobine
[уреди | уреди извор]| Osobina | Vrednost |
|---|---|
| Broj akceptora vodonika | 23 |
| Broj donora vodonika | 16 |
| Broj rotacionih veza | 18 |
| Particioni koeficijent[13] (ALogP) | -3,1 |
| Rastvorljivost[14] (logS, log(mol/L)) | -10,3 |
| Polarna površina[15] (PSA, Å2) | 518,5 |
Reference
[уреди | уреди извор]- ^ Grover, N. D. (2010). . „Echinocandins: A ray of hope in antifungal drug therapy”. Indian J Pharmacol. 42 (1): 9—11. PMC 2885632
. PMID 20606829. doi:10.4103/0253-7613.62396
.
- ^ Bormann, A. M.; Morrison, V. A. (2009). . „20054447”. Drug Design, Development and Therapy. 3: 295—302. PMC 2802128
. PMID 20054447. doi:10.2147/dddt.s3242
.
- ^ Vehreschild, J. J.; Cornely, O. A. (2006). . „Micafungin Sodium, the Second of the Echinocandin Class of Antifungals: Theory and Practice”. Future Microbiology. 1 (2): 161—170. PMID 17661660. doi:10.2217/17460913.1.2.161.
- ^ Groll, A. H.; Stergiopoulou, T.; Roilides, E.; Walsh, T. J. (2005). . „Micafungin: Pharmacology, experimental therapeutics and clinical applications”. Expert Opinion on Investigational Drugs. 14 (4): 489—509. PMID 15882123. doi:10.1517/13543784.14.4.489.
- ^ Chandrasekar, P. H.; Sobel, J. D. (2006). . „Micafungin: A New Echinocandin”. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 42 (8): 1171—1178. PMID 16575738. doi:10.1086/501020.
- ^ Wiederhold, N. P.; Lewis Js, 2nd (2007). . „The echinocandin micafungin: A review of the pharmacology, spectrum of activity, clinical efficacy and safety”. Expert Opinion on Pharmacotherapy. 8 (8): 1155—1166. PMID 17516879. doi:10.1517/14656566.8.8.1155.
- ^ Ikeda, F.; Tanaka, S.; Ohki, H.; Matsumoto, S.; Maki, K.; Katashima, M.; Barrett, D.; Aoki, Y. (2007). . „Role of Micafungin in the Antifungal Armamentarium”. Current Medicinal Chemistry. 14 (11): 1263—1275. PMID 17504145. doi:10.2174/092986707780597970.
- ^ Sucher, A. J.; Chahine, E. B.; Balcer, H. E. (2009). . „Echinocandins: The Newest Class of Antifungals”. The Annals of Pharmacotherapy. 43 (10): 1647—1657. PMID 19724014. doi:10.1345/aph.1M237.
- ^ Morris, M. I.; Villmann, M. (2006). . „Echinocandins in the management of invasive fungal infections, part 1”. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 63 (18): 1693—2303. PMID 16960253. doi:10.2146/ajhp050464.p1.
- ^ Morris, M. I.; Villmann, M. (2006). . „Echinocandins in the management of invasive fungal infections, part 2”. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 63 (19): 1813—1820. PMID 16990627. doi:10.2146/ajhp050464.p2.
- ^ Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). . „DrugBank 3.0: A comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—41. PMC 3013709
. PMID 21059682. doi:10.1093/nar/gkq1126.
- ^ Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. (2008). . „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—6. PMC 2238889
. PMID 18048412. doi:10.1093/nar/gkm958.
- ^ . . doi:10.1021/jp980230o. Недостаје или је празан параметар
|title=(помоћ) - ^ Tetko, I. V.; Tanchuk, V. Y.; Kasheva, T. N.; Villa, A. E. (2001). . „Estimation of aqueous solubility of chemical compounds using E-state indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
- ^ Ertl, P.; Rohde, B.; Selzer, P. (2000). . „Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e.
Literatura
[уреди | уреди извор]- Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
- Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.
Spoljašnje veze
[уреди | уреди извор]
| Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |